Medtronic MDT Non-US — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's non-us — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's non-us — net sales?
- Medtronic (MDT) reported non-us — net sales of $4.94B in Q1 2026.
- How has Medtronic's non-us — net sales changed year-over-year?
- Medtronic's non-us — net sales increased by 12.8% year-over-year, from $4.38B to $4.94B.
- What is the long-term trend for Medtronic's non-us — net sales?
- Over 3 years (2023 to 2026), Medtronic's non-us — net sales has grown at a 7.1% compound annual growth rate (CAGR), from $14.85B to $18.26B.
- What does non-us — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and therapeutic solutions in markets outside of the company's primary domestic region. It reflects the company's global footprint and its ability to navigate diverse regulatory environments, healthcare reimbursement systems, and competitive landscapes across international territories. Monitoring this figure is essential for assessing the company's geographic diversification and its success in capturing growth in emerging and developed global markets.